A placebo-controlled Phase 2 study of varoglutamstat in stage 3b/4 Diabetic Kidney Disease patients on top of SoC
Latest Information Update: 29 Oct 2024
At a glance
- Drugs Varoglutamstat (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 29 Oct 2024 New trial record